1 / 18

Harbarth S, Monnet DL, Pechère JC, Cars O.

Policy-Relevant Determinants for the Control of Macrolide-Resistant Streptococcus pneumoniae : Do International Comparisons Help?. Harbarth S, Monnet DL, Pechère JC, Cars O. BACKGROUND. Evaluating policy-relevant determinants of antibiotic overuse and bacterial resistance is a complex task.

omana
Download Presentation

Harbarth S, Monnet DL, Pechère JC, Cars O.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Policy-Relevant Determinants for the Control of Macrolide-Resistant Streptococcus pneumoniae: Do International Comparisons Help? Harbarth S, Monnet DL, Pechère JC, Cars O.

  2. BACKGROUND • Evaluating policy-relevant determinants of antibiotic overuse and bacterial resistance is a complex task. • Standardized assessment of these determinants may enable cross-cultural comparisons and allow policy makers to identify and implement those control measures that are the most likely to be successful.

  3. Penicillin-resistant pneumococci and outpatient AB-use 60 Taiwan 50 Spain France 40 USA Greece 30 Portugal Penicillin-nonsusceptible S. pneumoniae (%) This is where a large graphic or chart can go. Ireland 20 Canada Luxemburg Iceland Italy Austria Belgium UK 10 Australia Germany Albrich, Monnet & Harbarth, Emerg Infect Dis 2004 Finland Sweden Denmark Netherlands Norway 0 0 10 20 30 40 Total antibiotic use (DDD/1000 pop/day)

  4. OBJECTIVES • The purpose of this retrospective, ecologic study was to explore macro-level determinants explaining the large variation in MRSP prevalence in 14 European countries. • Specifically, we attempted to test different hypotheses (e.g., antibiotic usage patterns, population characteristics) linked to low or high MRSP prevalence.

  5. Prescriberfactors Patient factors Antibiotic overuse and misuse Antibiotic-resistant pneumococci Cultural influences Social determinants Regulatory practices Macro-level determinants influencing AB overuse Harbarth et al, Emerg Infect Dis 2002; 8: 1460-1467

  6. METHODS • An extensive list of all possible determinants that might explain variations in MRSP prevalence was established. • Data on MRSP prevalence and explanatory factors were retrieved from electronic databases, reports from multinational and national surveillance systems, and international organizations. • Correlations were assessed with the 2-tailed Spearman coefficient for non-parametric correlations.

  7. Lower use of macrolides • (less exposed, shorter duration) • Lower use of other antimicrobials • Better compliance (dose, intervals) • Pre-school facilities • Long-term care? • Better living conditions • Socio-economic status • Climate? • Less travel • Different clones More rational use of antibiotics? Lower Proportion of Macrolide-R S. pneumoniae in Community-Acquired RTIs Less cross-transmission? Better protection against disease? Different population? • Age (extremes) • Respiratory and other diseases • Vaccination • Breast feeding

  8. RESULTS

  9. Macrolide-Resistant Streptococcus pneumoniae and Macrolide Consumption in EU Member States, 1997-1998 Sources: Alexander Project, FINRES, STRAMA, DANMAP, and Cars O, et al. Lancet 2001; 357: 1851-3.

  10. Macrolide-R S. pneumoniae(%) and Antimicrobial Consumption in Europe This is where a large graphic or chart can go. Source for resistance data: Alexander Project. Source for antimicrobial consumption data: Cars O, et al. Lancet 2001; 357: 1851-3.

  11. Macrolide-R S. pneumoniae(%): Factors Affecting Compliance with Antibiotic Treatment This is where a large graphic or chart can go. Source: EUROBAROMETER 2002.

  12. Macrolide-R S. pneumoniae(%): Factors That Might Facilitate Cross-Transmission This is where a large graphic or chart can go. Sources: Danish National Institute of Social Research, EC Eurostat, and European Travel Commission (ETC) Tourism Statistics.

  13. Macrolide-R S. pneumoniae (%): Population Characteristics and Protection against Disease This is where a large graphic or chart can go. Sources: U.S. Bureau of the Census, EC Eurostat, WHO Regional Office for Europe, and Fedson DS. Clin Infect Dis 1998;26:1117-23.

  14. Macrolide-R S. pneumoniae(%):Economic and Health Care System This is where a large graphic or chart can go. Responsiveness of health system is a measure of how the system performs relative to non-health aspects (e.g. choice of provider, client orientation) thus meeting or not meeting the population’s expectations of how it should be treated by providers of care. Source: World Health Report 2000.

  15. Macrolide-R S. pneumoniae(%):Culture Determinants This is where a large graphic or chart can go. Power distance is a measure of the interpersonal power or influence between two individuals when one is the subordinate of the other. Uncertainty avoidance is a measure of tolerance to ambiguous situations, which leads some individuals to feel more pressed for action than others. Masculinity is a measure of the implications that differences between the sexes should have for the emotional and social roles of the genders. Individualism is a measure of the relation between the individual and the collectivity that prevails in a society and is reflected in the way people live together. Long-term orientation is based on the long-term aspects of Confucius thinking: persistence and thrift to personal stability, and respect for tradition. Source: HOFSTEDE.

  16. Summary • Determinants positively correlated with MRSP prevalence: • Use of macrolides and other antibiotic classes (e.g., cephalosporins) • Misuse of antibiotics (low compliance, self-medication with antibiotics) • Factors facilitating cross-transmission of MRSP (having children at home, attendance of daycare, foreign travel) • Determinants negatively correlated with MRSP prevalence: • Use of narrow-spectrum penicillins • Protection against infectious diseases (breastfeeding, general vaccination coverage of infants, and physical activity of adults) • Responsiveness of the health system • No correlation at the macro-level for several determinants that were presented as hypotheses (e.g., population density, socio-economic status)

  17. Discussion & Conclusions • A substantial part of the problem is certainly due to antimicrobial use! • Hypotheses should be tested in future research • Problem of multiple statistical testing • Further multivariate analyses will be performed • Several determinants already appear as candidates for confirmatory studies at the patient level and potential targets for interventions in countries with high prevalence of MRSP: • Increase breastfeeding and immunization coverage • Decrease daycare attendance in early life (< 1y) • Decrease self-medication and OTC sales • Decrease non rational use of macrolides

More Related